Image 1 of 1
2021-03-31-Lacen Labs-152.jpg
A lab technician holds a sample taken from an RT-PCR test inside the liquid to preserve it for testing at Lacen Central Laboratory March 30, 2021 in Manaus, Brazil. Brazilian residences are receiving the CoronaVac vaccine, also known as the Sinovac COVID-19 vaccine. CoronaVac is an inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech and has been in Brazil's Phase III clinical trials. Photo Ken Cedeno

